Cite

HARVARD Citation

    Hironaka, S. et al. (n.d.). Phase I/II trial of 2‐weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (JCOG0807). Cancer science. 105 (9), pp. 1189-1195. [Online]. 
  
Back to record